These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 38710000

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Tumefactive Demyelination in MOG Ab-Associated Disease, Multiple Sclerosis, and AQP-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder.
    Cacciaguerra L, Morris P, Tobin WO, Chen JJ, Banks SA, Elsbernd P, Redenbaugh V, Tillema JM, Montini F, Sechi E, Lopez-Chiriboga AS, Zalewski N, Guo Y, Rocca MA, Filippi M, Pittock SJ, Lucchinetti CF, Flanagan EP.
    Neurology; 2023 Mar 28; 100(13):e1418-e1432. PubMed ID: 36690455
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Brain structural alterations in MOG antibody diseases: a comparative study with AQP4 seropositive NMOSD and MS.
    Duan Y, Zhuo Z, Li H, Tian DC, Li Y, Yang L, Gao C, Zhang T, Zhang X, Shi FD, Barkhof F, Liu Y.
    J Neurol Neurosurg Psychiatry; 2021 Jul 28; 92(7):709-716. PubMed ID: 33687975
    [Abstract] [Full Text] [Related]

  • 8. Frequency of New or Enlarging Lesions on MRI Outside of Clinical Attacks in Patients With MOG-Antibody-Associated Disease.
    Syc-Mazurek SB, Chen JJ, Morris P, Sechi E, Mandrekar J, Tillema JM, Lopez-Chiriboga AS, Lucchinetti CF, Zalewski N, Cacciaguerra L, Buciuc M, Krecke KN, Messina SA, Bhatti MT, Pittock SJ, Flanagan EP.
    Neurology; 2022 Oct 31; 99(18):795-799. PubMed ID: 36175150
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The burden of psychiatric morbidity in Multiple Sclerosis, AQP4-antibody NMOSD and MOGAD before and after neurological diagnosis.
    Tan YY, Saffari SE, Tye JSN, Peng X, Koh MJ, Mahmood ABSB, Tan JMM, Tan K, Yeo T.
    Mult Scler Relat Disord; 2024 Sep 31; 89():105775. PubMed ID: 39053396
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Marked central canal T2-hyperintensity in MOGAD myelitis and comparison to NMOSD and MS.
    Webb LM, Cacciaguerra L, Krecke KN, Chen JJ, Sechi E, Redenbaugh V, Dubey D, Pittock SJ, Flanagan EP.
    J Neurol Sci; 2023 Jul 15; 450():120687. PubMed ID: 37201267
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Clinical and immunological differences between MOG associated disease and anti AQP4 antibody-positive neuromyelitis optica spectrum disorders: Blood-brain barrier breakdown and peripheral plasmablasts.
    Tanaka S, Hashimoto B, Izaki S, Oji S, Fukaura H, Nomura K.
    Mult Scler Relat Disord; 2020 Jun 15; 41():102005. PubMed ID: 32114369
    [Abstract] [Full Text] [Related]

  • 18. Contrasting the brain imaging features of MOG-antibody disease, with AQP4-antibody NMOSD and multiple sclerosis.
    Messina S, Mariano R, Roca-Fernandez A, Cavey A, Jurynczyk M, Leite MI, Calabrese M, Jenkinson M, Palace J.
    Mult Scler; 2022 Feb 15; 28(2):217-227. PubMed ID: 34048323
    [Abstract] [Full Text] [Related]

  • 19. Anti-MOG associated disorder-Clinical and radiological characteristics compared to AQP4-IgG+ NMOSD-A single-center experience.
    Rempe T, Tarhan B, Rodriguez E, Viswanathan VT, Gyang TV, Carlson A, Tuna IS, Rees J.
    Mult Scler Relat Disord; 2021 Feb 15; 48():102718. PubMed ID: 33388560
    [Abstract] [Full Text] [Related]

  • 20. Clinicoradiological comparative study of Aquaporin-4-IgG seropositive neuromyelitis optica spectrum disorder (NMOSD) and MOG antibody associated disease (MOGAD): A prospective observational study and review of literature.
    Nagireddy RBR, Kumar A, Singh VK, Prasad R, Pathak A, Chaurasia RN, Mishra VN, Joshi D.
    J Neuroimmunol; 2021 Dec 15; 361():577742. PubMed ID: 34655992
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.